Profits Comeback Paired With Rate Cuts Make a Powerful Mix

Profits are growing again, and the Federal Reserve looks as if it will start cutting rates…

Merck to Buy Harpoon Therapeutics for $680 Million

Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680…

The Stocks That AI Mania Left Behind

This was supposed to be the year value stocks shined. Then AI mania took over and…

Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame.

Wall Street has slashed its estimates for corporate profits in the final months of 2023. Yet…

Big Pharma’s Battle With the Biden Administration Could Have Legs

Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the…

Microchips in the Parmigiano and Other Ways Europeans Are Fighting Fake Food

Parmesan producers are among those seeking ways to their protect billion-dollar markets.

Get In on This Skin Disease Drug Before Big Pharma Does

What to Read Next

Big Pharma Bets Big on China

China remains attractive to global pharmaceutical companies, even as many multinationals are turning their attention elsewhere.

Companies Try New Strategy to Stay in China: Siloing

As tensions rise between Washington and Beijing, companies are looking for ways to shut down business…

Companies Brace for Supreme Court Ruling on Affirmative Action

Decisions on race-conscious college admissions may have implications for corporate diversity programs.